Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.
Keywords: androgenetic alopecia; finasteride; hair loss; hair transplantation; minoxidil; platelet-rich plasma.
Copyright © 2023. Published by Elsevier Inc.